Determination of doxorubicin in rabbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxorubicin-loaded poly-β-hydroxybutyrate microspheres

被引:36
作者
Hu, Tao
Le, Qihua
Wu, Zhiyi
Wu, Wei [1 ]
机构
[1] Fudan Univ, Sch Pharm, Shanghai 200032, Peoples R China
[2] Fudan Univ, Eye & ENT Hosp, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
doxorubicin; microspheres; RP-HPLC; pharmacokinetics; ocular;
D O I
10.1016/j.jpba.2006.06.032
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
A validated HPLC method was developed for the quantification of doxorubicin in rabbit ocular tissues using solid phase extraction and ultraviolet detection. Chromatographic separation of doxorubicin in various ocular tissues was performed on a C18 column. The mobile phase was composed of 0.2M KH2PO4 buffer solution, acetonitrile and triethylamine in volumetric ratio of 70/30/0.2, adjusted to pH 4.0 with orthophosphoric acid. The calibration curve was linear over the range of 0.03-10, 0.03-10, 0.05-10 and 0.05-10 mu g/ml in vitreous body, iris, retina/choroids and sclera, respectively. The intra-day and inter-day precisions in all ocular tissues were smaller than 4.95% and 5.73%, and the accuracies were about 100%. The extraction recoveries of doxorubicin in all of the ocular tissues were between 83.47% and 96.33%. After intravitreal administration of doxorubicin-loaded poly-beta-hydroxybutyrate microspheres, doxorubicin level in ocular tissues was much lower than that for administration of free doxorubicin, which was helpful to reduce the associated toxicity to surrounding tissues. Doxorubicin was detectable even after tens of days in the studied ocular tissues. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:263 / 269
页数:7
相关论文
共 30 条
[1]
High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues [J].
Alvarez-Cedrón, L ;
Sayalero, ML ;
Lanao, JM .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 721 (02) :271-278
[2]
ARCAMONE F, 1984, CANCER CHEMOTH PHARM, V12, P157
[3]
BLUMENKRANZ M, 1984, OPHTHALMOLOGY, V91, P122
[4]
ANTHRACYCLINE ANTIBIOTICS IN CANCER-THERAPY - FOCUS ON DRUG-RESISTANCE [J].
BOOSER, DJ ;
HORTOBAGYI, GN .
DRUGS, 1994, 47 (02) :223-258
[5]
SUPPRESSION OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY BY SUSTAINED INTRAOCULAR DELIVERY OF 5-FU [J].
BORHANI, H ;
PEYMAN, GA ;
RAHIMY, MH ;
THOMPSON, H .
INTERNATIONAL OPHTHALMOLOGY, 1995, 19 (01) :43-49
[6]
Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography [J].
Chin, DL ;
Lum, BL ;
Sikic, BI .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 779 (02) :259-269
[7]
HPLC methods for the determination of bound and free doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugates [J].
Configliacchi, E ;
Razzano, G ;
Rizzo, V ;
Vigevani, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 15 (01) :123-129
[8]
Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro in vivo evaluation [J].
Conti, B ;
Bucolo, C ;
Giannavola, C ;
Puglisi, G ;
Giunchedi, P ;
Conte, U .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 5 (05) :287-293
[9]
PHYSICOMECHANICAL PROPERTIES OF DEGRADABLE POLYMERS USED IN MEDICAL APPLICATIONS - A COMPARATIVE-STUDY [J].
ENGELBERG, I ;
KOHN, J .
BIOMATERIALS, 1991, 12 (03) :292-304
[10]
FLUORESCENCE ASSAYS AND PHARMACOKINETIC STUDIES OF 4'-DEOXYDOXORUBICIN AND DOXORUBICIN IN ORGANS OF MICE BEARING SOLID TUMORS [J].
FORMELLI, F ;
POLLINI, C ;
CASAZZA, AM ;
DIMARCO, A ;
MARIANI, A .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 5 (03) :139-144